Clinical Trial Update: Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease [Phase 3]

View source ↗

Summary

Phase 3 extension study evaluating the safety and efficacy of iron isomaltoside 1000 (Monofer) in subjects with inflammatory bowel disease and iron-deficiency a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Iron Deficiency Anemia
• Ulcerative Colitis

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Inflammatory Bowel Disease, Anaemia | Phase 3 | Status: COMPLETED